Your browser doesn't support javascript.
loading
[Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma]. / Complications d'un dispositif intraveineux implantable pour chimiothérapie dans les cancers des voies aérodigestives supérieures.
Hoareau-Gruchet, F; Rtail, R; Sulaj, H; Khirnetkina, A; Reyt, E; Righini, C A.
Afiliação
  • Hoareau-Gruchet F; Pôle tête et cou, chirurgie réparatrice, clinique ORL, CHU A.-Michallon, avenue du Maquis-du-Grésivaudan, BP 217, 38043 Grenoble cedex 9, France.
Ann Otolaryngol Chir Cervicofac ; 126(2): 43-52, 2009 Apr.
Article em Fr | MEDLINE | ID: mdl-19324328
OBJECTIVES: To review the occurrence of early and delayed complications after insertion of a totally implantable venous access port (Tivap) in patients treated with chemotherapy for head and neck squamous cell carcinoma. MATERIAL AND METHODS: Monocentric prospective study (2005-2008) undertaken in a tertiary referral center. In all cases, the inserted Tivap was a Celsite ST301 (Braun) model. The insertion procedure was performed in operating room conditions under local anesthesia using a surgical cut-down method. No antibiotic prophylaxis or long-term anticoagulant medications were administered. Two groups were made between experienced and in-training surgeons. All complications occurring from the date of Tivap insertion to the date of its removal or until the closure of the study were included. RESULTS: The study comprised of 122 patients including 103 males and 19 females; the patients' mean age was 58.5 years (range, 36-80). Twelve (9.8%) had a tracheotomy or tracheostomy and 41 (33.6%) underwent cervical radiotherapy before Tivap insertion. In 63 cases (51.6%), the procedure was performed by a senior surgeon. The inserted vessel was the cephalic vein (84.4%), the external jugular vein (11.5%) or the internal jugular vein (2.5%). Overall, the total number of days of Tivap implantation was 51,403. Altogether, 11 complications (9%) were listed: two (1.6%) early complications and nine (7.4%) delayed complications. We did not uncover a significant statistical relation between complication onset and experience of the operating surgeon, sex, implanted side, tracheotomy, previous radiotherapy, or number of days of Tivap port. CONCLUSION: Our study suggests that: (1) complications are rare provided careful implantation and manipulation methods are followed by health personnel; (2) surgical cephalic cut-down is a very reliable method; and 3) antibiotic prophylaxis or long-term anticoagulant medications are not mandatory.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cateterismo Venoso Central / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Bombas de Infusão Implantáveis / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Fr Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cateterismo Venoso Central / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Bombas de Infusão Implantáveis / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Fr Ano de publicação: 2009 Tipo de documento: Article